vs
GREAT SOUTHERN BANCORP, INC.（GSBC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是GREAT SOUTHERN BANCORP, INC.的1.3倍（$75.5M vs $56.4M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -0.2%），GREAT SOUTHERN BANCORP, INC.自由现金流更多（$70.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 4.5%）
该企业是美国的多元化银行金融机构，总部位于明尼苏达州明尼阿波利斯，在特拉华州注册。截至2025年，它是美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构，主营零售及企业银行业务、投资、抵押贷款等多元金融服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GSBC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$56.4M
营收增速更快
PBYI
高出27.9%
-0.2%
自由现金流更多
GSBC
多$55.7M
$14.4M
两年增速更快
PBYI
近两年复合增速
4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.4M | $75.5M |
| 净利润 | $16.3M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 34.5% | 22.7% |
| 净利率 | 28.9% | — |
| 营收同比 | -0.2% | 27.7% |
| 净利润同比 | 9.1% | — |
| 每股收益（稀释后） | $1.44 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GSBCPBYI
| Q4 25 | $56.4M | $75.5M | ||
| Q3 25 | $57.8M | $54.5M | ||
| Q2 25 | $59.2M | $52.4M | ||
| Q1 25 | $55.9M | $46.0M | ||
| Q4 24 | $56.5M | $59.1M | ||
| Q3 24 | $55.0M | $80.5M | ||
| Q2 24 | $56.7M | $47.1M | ||
| Q1 24 | $51.6M | $43.8M |
净利润GSBCPBYI
| Q4 25 | $16.3M | — | ||
| Q3 25 | $17.8M | $8.8M | ||
| Q2 25 | $19.8M | $5.9M | ||
| Q1 25 | $17.2M | $3.0M | ||
| Q4 24 | $14.9M | — | ||
| Q3 24 | $16.5M | $20.3M | ||
| Q2 24 | $17.0M | $-4.5M | ||
| Q1 24 | $13.4M | $-4.8M |
毛利率GSBCPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率GSBCPBYI
| Q4 25 | 34.5% | 22.7% | ||
| Q3 25 | 38.2% | 17.6% | ||
| Q2 25 | 41.0% | 12.7% | ||
| Q1 25 | 38.4% | 8.7% | ||
| Q4 24 | 31.8% | 22.6% | ||
| Q3 24 | 36.6% | 27.4% | ||
| Q2 24 | 36.8% | -4.6% | ||
| Q1 24 | 32.1% | -5.3% |
净利率GSBCPBYI
| Q4 25 | 28.9% | — | ||
| Q3 25 | 30.7% | 16.2% | ||
| Q2 25 | 33.4% | 11.2% | ||
| Q1 25 | 30.7% | 6.5% | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 30.0% | 25.2% | ||
| Q2 24 | 30.0% | -9.6% | ||
| Q1 24 | 26.0% | -11.0% |
每股收益（稀释后）GSBCPBYI
| Q4 25 | $1.44 | $0.26 | ||
| Q3 25 | $1.56 | $0.17 | ||
| Q2 25 | $1.72 | $0.12 | ||
| Q1 25 | $1.47 | $0.06 | ||
| Q4 24 | $1.27 | $0.40 | ||
| Q3 24 | $1.41 | $0.41 | ||
| Q2 24 | $1.45 | $-0.09 | ||
| Q1 24 | $1.13 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $189.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $636.1M | $130.3M |
| 总资产 | $5.6B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GSBCPBYI
| Q4 25 | $189.6M | $97.5M | ||
| Q3 25 | $196.2M | $94.4M | ||
| Q2 25 | $245.9M | $96.0M | ||
| Q1 25 | $217.2M | $93.2M | ||
| Q4 24 | $195.8M | $101.0M | ||
| Q3 24 | $208.4M | $96.7M | ||
| Q2 24 | $186.5M | $96.8M | ||
| Q1 24 | $171.4M | $107.2M |
总债务GSBCPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益GSBCPBYI
| Q4 25 | $636.1M | $130.3M | ||
| Q3 25 | $632.9M | $115.3M | ||
| Q2 25 | $622.4M | $104.7M | ||
| Q1 25 | $613.3M | $97.1M | ||
| Q4 24 | $599.6M | $92.1M | ||
| Q3 24 | $612.1M | $71.1M | ||
| Q2 24 | $568.8M | $48.5M | ||
| Q1 24 | $565.2M | $51.0M |
总资产GSBCPBYI
| Q4 25 | $5.6B | $216.3M | ||
| Q3 25 | $5.7B | $202.9M | ||
| Q2 25 | $5.9B | $194.9M | ||
| Q1 25 | $6.0B | $196.2M | ||
| Q4 24 | $6.0B | $213.3M | ||
| Q3 24 | $6.0B | $220.7M | ||
| Q2 24 | $6.0B | $205.0M | ||
| Q1 24 | $5.8B | $214.1M |
负债/权益比GSBCPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $81.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $70.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 124.3% | 19.1% |
| 资本支出强度资本支出/营收 | 20.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 5.01× | — |
| 过去12个月自由现金流最近4个季度 | $121.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流GSBCPBYI
| Q4 25 | $81.5M | $14.4M | ||
| Q3 25 | $5.6M | $9.7M | ||
| Q2 25 | $39.3M | $14.1M | ||
| Q1 25 | $15.0M | $3.6M | ||
| Q4 24 | $44.1M | $15.6M | ||
| Q3 24 | $17.7M | $11.0M | ||
| Q2 24 | $43.5M | $1.0M | ||
| Q1 24 | $-26.9M | $11.2M |
自由现金流GSBCPBYI
| Q4 25 | $70.1M | $14.4M | ||
| Q3 25 | $3.9M | $9.7M | ||
| Q2 25 | $34.9M | $14.1M | ||
| Q1 25 | $13.1M | $3.6M | ||
| Q4 24 | $39.1M | $15.6M | ||
| Q3 24 | $16.5M | $11.0M | ||
| Q2 24 | $42.0M | $1.0M | ||
| Q1 24 | $-27.7M | — |
自由现金流率GSBCPBYI
| Q4 25 | 124.3% | 19.1% | ||
| Q3 25 | 6.7% | 17.7% | ||
| Q2 25 | 59.0% | 26.8% | ||
| Q1 25 | 23.4% | 7.7% | ||
| Q4 24 | 69.3% | 26.4% | ||
| Q3 24 | 30.1% | 13.7% | ||
| Q2 24 | 74.1% | 2.1% | ||
| Q1 24 | -53.7% | — |
资本支出强度GSBCPBYI
| Q4 25 | 20.3% | 0.0% | ||
| Q3 25 | 3.0% | 0.0% | ||
| Q2 25 | 7.4% | 0.0% | ||
| Q1 25 | 3.5% | 0.1% | ||
| Q4 24 | 8.7% | 0.0% | ||
| Q3 24 | 2.1% | 0.0% | ||
| Q2 24 | 2.7% | 0.0% | ||
| Q1 24 | 1.6% | 0.0% |
现金转化率GSBCPBYI
| Q4 25 | 5.01× | — | ||
| Q3 25 | 0.31× | 1.10× | ||
| Q2 25 | 1.99× | 2.41× | ||
| Q1 25 | 0.87× | 1.21× | ||
| Q4 24 | 2.95× | — | ||
| Q3 24 | 1.07× | 0.54× | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | -2.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
